Science & Technology
Sbir Concept Award for Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers and/or Rare Cancers
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N91025C00038
Award Ceiling
$355K
Award Floor
$355K
Close Date
N/A
Total Funding
$355K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N91025C00038
Description
SBIR Phase Phase I award: "SBIR CONCEPT AWARD FOR DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS" awarded to METACLIPSE THERAPEUTICS CORP in ATLANTA, Georgia. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $354,957. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Socially/economically disadvantaged
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.